Search filters

List of works by Philippe Sogni

All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort

scientific article published on 17 June 2016

Benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection.

scientific article published on 10 March 2012

Brief communication: case reports of ribavirin treatment for chronic hepatitis E.

scientific article published on 14 June 2010

Chronic hepatitis E in patients with indolent lymphoma after treatment with rituximab and bendamustine

scientific article

Chronic liver disease: systemic and splanchnic venous flow mapping with optimized cine phase-contrast MR imaging validated in a phantom model and prospectively evaluated in patients

article

Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus co-infected patients (ANRS CO13-HEPAVIH).

scientific article published on 6 October 2017

Effect of nucleoside and nucleotide analogues on renal function in patients with chronic hepatitis B virus monoinfection.

scientific article published on 21 November 2014

Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort

scientific article

Evolution of patients' socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients.

scientific article published on 5 July 2018

Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients

article

Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib

scientific article

Impact of Alcohol and Coffee Intake on the Risk of Advanced Liver Fibrosis: A Longitudinal Analysis in HIV-HCV Coinfected Patients (ANRS HEPAVIH CO-13 Cohort).

scientific article published on 31 May 2018

Impact of Obliterative Portal Venopathy Associated With Human Immunodeficiency Virus

scientific article

Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study

scientific article published in PLoS ONE

Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastography.

scientific article published on 22 September 2014

Life after hepatitis C cure in HIV-infected people who inject drugs and men who have sex with men treated with direct-acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH)

scientific article published on 18 August 2020

Management of hepatitis C virus infection in heavy drinkers

scientific article published on 21 March 2013

Nadir CD4 Is Negatively Associated With Antinuclear Antibody Detection in HCV/HIV-Coinfected Patients

scientific article published on 01 April 2019

No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort).

scientific article published on 13 April 2016

Patients with chronic hepatitis B should be screened for hepatocellular carcinoma regardless of liver stiffness measurement

scientific article published on 23 May 2015

Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers

scientific article published on 8 March 2012

The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): Early findings, 2006-2010

scientific article published on October 22, 2010

The impact of coffee consumption on fibrosis and steatosis in HIV-HCV co-infected patients

scientific article published on 2 November 2017

The role of adherence in virological suppression in patients receiving anti-HBV analogues

scientific article published on 03 November 2011

Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients

scientific article